California Selects Pear Therapeutics For Contingency Management Recovery Incentives Program For Stimulant Use Disorder

The California Department of Health Care Services (DHCS) selected Pear Therapeutics for a contract to track and distribute incentives for the state’s new Medicaid Recovery Incentives: California’s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder. The pilot program will allow eligible Medi-Cal members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services. Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution . . .